Outcome of philadelphia chromosome-positive adult acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 36, Issue 3-4, 2000, Pages 263-273

  Faderl, Stefan ^a   Kantarjian, Hagop M ^a   Thomas, Deborah A ^a   Cortes, Jorge ^a   Giles, Francis ^a   Pierce, Sherry ^a   Albitar, Maher ^b   Estrov, Zeev ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Laboratory Medicine   (United States)

Author keywords

Acute lymphoblastic leukemia; Adult acute leukemias; Intensive chemotherapy; Philadelphia chromosome; Survival

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE; ARTICLE; BLAST CELL; BONE MARROW BIOPSY; CANCER SURVIVAL; CELL COUNT; CYTOGENETICS; FEMALE; HUMAN; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; REMISSION;

EID: 0033954540     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009148847     Document Type: Article

References (29)

1. Faderl, S., Kantarjian, H.M., Talpaz, M., Estrov, Z. (1998) Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood, 91, 3955-4019.
2. Third International Workshop on Chromosomes in Leukemia. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. (1983) Cancer Res, 43, 868-873.
3. Groupe Français de Cytogénétique Hématologique: Cytogenetic abnormalities in adult acute lymphoblastic leukemia. Correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de Cytogénétique Hématologique. (1996) Blood, 87, 3135-3142.
4. Rieder, H., Ludwig, W.-D., Gassmann, W., Thiel, E., Löffler, H., Hoelzer, D., Fonatsch, C. (1993) Chromosomal abnormalities in adult acute lymphoblastic leukemia: Results of the German ALL/AUL study group. Recent Results Cancer Res, 131, 133-148.
5. 3. Hematol Oncol, 7, 307-317.
6. Seeker-Walker, L.M., Prentice, H.G., Durrant, J., Richards, S., Hall, E., Harrison, G. (1997) Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol, 96, 601-610.
7. Bloomfield, C.D., Seeker-Walker, L.M., Goldman, A.I., Van Den Berghe, H., de la Chapelle, A., Ruutu, T., Alimena, G., Garson, O.M., Golomb, H.M., Rowley, J.D., Kaneko, Y., Whang-Peng, J., Prigogina, E., Philip, P., Sandberg, A.A., Lawler, S.D., Mitelman, F. (1989) Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet, 40, 171-185.
8. Nowell, P.C., Hungerford, D.A. (1960) A minute chromosome in human chronic granulocytic leukemia. Science, 132, 1497.
9. Kurzrock, R., Gutterman, J.U., Talpaz, M. (1988) The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med, 319, 990-998.
10. Kantarjian, H.M., Talpaz, M., Dhingra, K., Estey, E., Keating, M.J., Ku, S., Trujillo, J., Huh, Y., Stass, S., Kurzrock, R. (1991) Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood, 78, 2411-2418.
11. Preti, H.A., O'Brien, S., Giralt, S., Beran, M., Pierce, S., Kantarjian, H.M. (1994) Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patients. Am J Med, 97, 60-65.
12. Götz, G., Weh, H.-J., Walter, T.A., Kuse, R., Kolbe, K., Dölken, G., Hellriegel, K.P., Hoelzer, D., Hossfeld, D.K. (1992) Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia. Ann Hematol, 64, 97-100.
13. Maurer, J., Janssen, J.W.G., Thiel, E., Van Denderen, J., Ludwig, W.-D., Aydemir, Ü., Heinze, B., Fonatsch, C., Harbott, J., Reiter, A., Riehm, H., Hoelzer, D., Bartram, C.R. (1991) Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet, 337, 3995-4019.
14. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., Sultan, C. (1976) Proposals for the classification of acute leukemia. Br J Haematol, 33, 451-458.
15. Kantarjian, H.M., Walters, R.S., Keating, M.J., Smith, T.L., O'Brien, S., Estey, E.H., Huh, Y.O., Spinolo, J., Dicke, K., Barlogie, B., McCredie, K.B., Freireich, E.J. (1990) Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard-and high-risk acute lymphocytic leukemia. J Clin Oncol, 8, 994-1004.
16. Keating, M.J., Cork, A., Broach, Y., Smith, T., Walters, R.S., McCredie, K.B., Trujillo, J., Freireich, E.J. (1987) Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leuk Res, 11, 119-133.
17. Murphy, S.B., Bowman, W.P., Abromowitch, M., Mirro, J., Ochs, J., Rivera, G., Pui, C.H., Fairclough, D., Berard, C.W. (1986) Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol, 4, 1732-1739.
18. Kantarjian, H., O'Brien, S., Beran, M., Keating, M., Koller, C., Robertson, L., Andreeff, M., Murphy, S., Freireich. E.J. (1995) Update of the hyper-CVAD program in newly diagnosed adult acute lymphocytic leukemia (ALL). Blood, 86, 173a (abstr).
19. Keating, M.J., Gehan, E.A., Smith, T.L., Estey, E.H., Walters, R.S., Kantarjian, H.M., McCredie, K.B., Freireich, E.J. (1987) A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia. J Clin Oncol, 5, 710-721.
20. Kaplan, E.S., Meier, P. (1958) Non-parametric estimations form incomplete observations. Am Stat Assoc J, 53, 457.
21. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep, 50, 163.
22. 1-patients. Br J Haematol, 36, 347-358.
23. Specchia, G., Mininni, D., Guerrasio, A., Palumbo, G., Pastore, D., Liso, V. (1995) Ph positive acute lymphoblastic leukemia in adults: molecular and clinical studies. Leuk Lymphoma, 18 (Suppl 1), 37-42.
24. Koller, C.A., Kantarjian, H.M., Thomas, D., O'Brien, S., Rios, M.B., Kornblau, S., Murphy, S., Keating, M. (1997) The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia, 11, 2039-2044.
25. Rieder, H., Ludwig, W.-D., Gassmann, W., Maurer, J., Janssen, J.W.G., Gökbuget, N., Schwartz, S., Thiel, E., Löffler, H., Bartram, C.R., Hoelzer, D., Fonatsch, C. (1996) Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome postivie acute lymphoblastic leukemia. Br J Haematol, 95, 678-691.
26. Secker-Walker, L.M., Craig, J.M., Hawkins, J.M., Hoffbrand, A.V. (1990) Philadelphia positive acute lymphoblastic leukemia in adults: age distribution. BCR breakpoint and prognostic significance. Leukemia, 5, 196-199.
27. Ribeiro, R.C., Broniscer, A., Rivera, G.K., Hancock, M.L., Raimondi, S.C., Sandlund, J.T., Crist, W., Evans, W.E., Pui, C.-H. (1997) Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia, 11, 1493-1496.
28. Thomas, X., Thiebaut, A., Olteanu, N., Danaíla, C., Charrin, C., Archimbaud, E., Fiere, D. (1998) Philadelphia chromosome postitive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome. Hematol Cell Ther, 40, 119.
29. Westbrook, C., Hooberman, A.L., Spino, C., Dodge, R.K., Larson, R.A., Davey, F., Wurster-Hill, D.H., Sobol, R.E., Schiffer, C., Bloomfield, C.D. (1992) Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B Study (8762). Blood, 80, 2983-2990.